These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18135521)
41. New Frontiers in the Treatment of Spinal Muscular Atrophy. Power CL; O'Rourke DJ Ir Med J; 2018 Mar; 111(3):705. PubMed ID: 30376223 [No Abstract] [Full Text] [Related]
42. Genetic therapies for spinal muscular atrophy type 1. Aartsma-Rus A Lancet Neurol; 2018 Feb; 17(2):111-112. PubMed ID: 29229374 [No Abstract] [Full Text] [Related]
43. Turning the tide in spinal muscular atrophy: A different respiratory course. Mayer OH Pediatr Pulmonol; 2019 Jul; 54(7):935-936. PubMed ID: 30884211 [No Abstract] [Full Text] [Related]
44. Progressive muscular atrophies. ARMSTRONG RA Univ Toronto Med J; 1949 Mar; 26(6):240-2. PubMed ID: 18116534 [No Abstract] [Full Text] [Related]
45. [Difficulty in surrogate decision making in spinal muscular atrophy type 1]. Laxe S An Pediatr (Barc); 2016 Sep; 85(3):165. PubMed ID: 27198884 [No Abstract] [Full Text] [Related]
46. Spinal muscular atrophy: some easy clues to diagnosis. Gupta PC; Ahuja B; Dhamija K; Mullick DN Indian Pediatr; 1989 Oct; 26(10):977-80. PubMed ID: 2630460 [TBL] [Abstract][Full Text] [Related]
47. Serum cholinesterase activity in infantile and juvenile spinal muscular atrophy. Niebroj-Dobosz I; Hausmanowa-Petrusewicz I Acta Neurol Scand; 1989 Sep; 80(3):208-14. PubMed ID: 2801018 [TBL] [Abstract][Full Text] [Related]
48. [Human leukocyte antigens in children with spinal muscular atrophy]. Májský A; Süssová J; Nevsímal O Cesk Neurol Neurochir; 1987 Sep; 50(5):304-9. PubMed ID: 3664731 [No Abstract] [Full Text] [Related]
49. Current and future treatments of spinal muscular atrophy. Smith M Dev Med Child Neurol; 2020 Mar; 62(3):267. PubMed ID: 31879942 [No Abstract] [Full Text] [Related]
50. Lumbosacral ventral spinal nerve root atrophy identified on MRI in a case of spinal muscular atrophy type II. Smith G; Bell SK; Sladky JT; Kang PB; Albayram MS Clin Imaging; 2019; 53():134-137. PubMed ID: 30340076 [TBL] [Abstract][Full Text] [Related]
51. Scoliosis in spinal muscular atrophy: natural history and management. Merlini L; Granata C; Bonfiglioli S; Marini ML; Cervellati S; Savini R Dev Med Child Neurol; 1989 Aug; 31(4):501-8. PubMed ID: 2680689 [TBL] [Abstract][Full Text] [Related]
52. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Gilliam TC; Brzustowicz LM; Castilla LH; Lehner T; Penchaszadeh GK; Daniels RJ; Byth BC; Knowles J; Hislop JE; Shapira Y Nature; 1990 Jun; 345(6278):823-5. PubMed ID: 1972783 [TBL] [Abstract][Full Text] [Related]
54. [Case of Werdnig-Hoffman's disease in an infant]. LUKASZEWICZ-DANCOWA D; WALENTYNOWICZ-STANCZYK R Pediatr Pol; 1956 Sep; 31(9):1031-4. PubMed ID: 13407985 [No Abstract] [Full Text] [Related]
55. Buying time for infants with spinal muscular atrophy. van der Pol L Lancet Neurol; 2021 Oct; 20(10):777-779. PubMed ID: 34536396 [No Abstract] [Full Text] [Related]
56. Spinal and bulbar muscular atrophy without tongue atrophy. Sugawara M; Kato K; Watanabe S; Toyoshima I Eur Neurol; 2001; 45(3):185-6. PubMed ID: 11306865 [No Abstract] [Full Text] [Related]